Andrew Hessel: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
No edit summary
No edit summary
Line 2: Line 2:




I consult in synthetic biology technology and education, open source biology, the international Genetically Engineered Machines (iGEM) program, DIYbio, and open innovation models with a focus on Canada.  I am also faculty and co-chair of the biotechnology and bioinformatics track at the [http://singularityu.org Singularity University].
I consult/network/evangelize synthetic biology technology and education, open source biology, the international Genetically Engineered Machines (iGEM) program, DIYbio, and open innovation models, with a focus on Canada.  I am also faculty and co-chair of the biotechnology and bioinformatics track at the [http://singularityu.org Singularity University].


My goal is to help grow a next-generation biotechnology industry better able to address environmental, health, and manufacturing concerns.  I accomplish this by raising awareness of the emerging tools and technologies with students, scientists, government officials, and business leaders; by facilitating introductions; and by helping groups or regions find the money and other resources necessary to do things.
My intention is to help develop a next-generation biotechnology industry – one that is better equipped to address major environmental, health, and manufacturing issues and deliver meaningful, effective, low-cost, and above all, safe solutions.  I work to accomplish this by raising awareness of the emerging tools and technologies with students, scientists, government officials, and business leaders; facilitating introductions and connections; and helping groups or regions find the money and other resources necessary to take practical step.


I advocate open source, incentive prizes, and fearlessness.
I am a co-founder, along with Jayson Tymko and John Carlson, of the world's first cooperative biotechnology company, the [http://pinkarmy.org Pink Army Cooperative].  Our inspiration is open source software successes like Apache and Linux that compete with billion-dollar software giants.  We believe open source biotechnology can do the same with big pharma, and we're creating a community of professionals to build our own drug development company.  We're focusing on breast cancer to start, and because we're structurally different than any other biotech or pharma, we can take novel approaches to making medicines.  


I am a co-founder, along with Jayson Tymko and John Carlson, of the world's first cooperative biotechnology company.  We out to build a community able to make individually-customized therapeutics with synthetic biology and give them away.  Open source competes well with IT giants, why not Big Pharma?


Please contact me if you are interested in learning about synthetic biology, creating iGEM or undergraduate programs in your area, how to change the world with biotechnology.
Please contact me if you are interested in learning about synthetic biology, creating iGEM or undergraduate programs in your area, how to change the world with biotechnology.

Revision as of 10:41, 22 November 2009


I consult/network/evangelize synthetic biology technology and education, open source biology, the international Genetically Engineered Machines (iGEM) program, DIYbio, and open innovation models, with a focus on Canada. I am also faculty and co-chair of the biotechnology and bioinformatics track at the Singularity University.

My intention is to help develop a next-generation biotechnology industry – one that is better equipped to address major environmental, health, and manufacturing issues and deliver meaningful, effective, low-cost, and above all, safe solutions. I work to accomplish this by raising awareness of the emerging tools and technologies with students, scientists, government officials, and business leaders; facilitating introductions and connections; and helping groups or regions find the money and other resources necessary to take practical step.

I am a co-founder, along with Jayson Tymko and John Carlson, of the world's first cooperative biotechnology company, the Pink Army Cooperative. Our inspiration is open source software successes like Apache and Linux that compete with billion-dollar software giants. We believe open source biotechnology can do the same with big pharma, and we're creating a community of professionals to build our own drug development company. We're focusing on breast cancer to start, and because we're structurally different than any other biotech or pharma, we can take novel approaches to making medicines.


Please contact me if you are interested in learning about synthetic biology, creating iGEM or undergraduate programs in your area, how to change the world with biotechnology.


Contact Information

LinkedIn profile hi-res photo
email: ahessel (at) gmail (dot) com
phone: 780.868.3169
Skype: search for "Andrew Hessel", ahessel (at) gmail (dot) com

2009 Talks, Conferences, Posters

The Drive to Innovate, Conoco-Phillips, Calgary, November 3, 2009

BIL:PIL, Building a Drug Development Pipeline for Personalized, Open Source Therapies for Breast Cancer. San Diego, October 30, 2009

TEDMED, San Diego, Oct 27-30, 2009 (attend)

SENS4, Cambridge, UK, September 3-7, 2009

Swedish-American Life Science Summit, Bionetworking Sessions, Stockholm, Sweden August 19-21, 2009

Singularity University, Introduction to synthetic biology and applications, July 20-21, 2009

iGEM Ontario Regional, University of Waterloo, May 29, 2009

SciBarCamp 2009, Toronto, May 8-9, 2009

Oil Sands Leadership Initiative keynote and meeting, Calgary, April 15-16, 2009

2008 Talks, Conferences, Posters

Convergence 08, Panel Debate, Talk, November 15-16, 2008

iGEM Jamboree, MIT, Cambridge, MA, November 7-9, 2008 (Chairing iGEM Canada session)

Singularity Summit 2008, San Jose, CA, October 25, 2008 (attending)

UofC Engineering, Calgary, Sept 24, 2008 (Engineering Biology)

SciFoo, Mountain View, CA, August 8-10, 2008

BioBarCamp, Palo Alto, CA, August 6-7, 2008

Science Cafe, Telus World of Science and Alberta Ingenuity, Edmonton, May 6, 2008

Sanofi Aventis BioTalent Challenge Keynote, Calgary, April 23, 2008

Sanofi Aventis BioTalent Challenge Keynote, Edmonton, April 16, 2008

Civil Society Synthetic Biology Teach-In, Washington DC, April 14, 2008 PDF

TEC Edmonton, Open Source Therapeutics, round 2, March 31, 2008

TEC Edmonton, Open Source Therapeutics, March 19, 2008

Overview of iGEM program, Edmonton Catholic School Board, March 18, 2008

Open Source Therapeutics. UofA Digital Biology Meeting, March 17, 2008

National Post Article on SciBarCamp by David Sachs.

Synbio Debate w/ Jim Thomas, ETC group; open source therapeutics scibarcamp, Toronto, May 14-16, 2008

Synthetic Biology and Nanotechnology: Opportunities and Implications for Alberta, Green Paper and Talk, Banff, March 5-6, 2008

Southern Alberta Institute of Technology (SAIT), Overview of Synthetic Biology, February 2008.

2007 Talks and Posters

iGEM and Synthetic Biology: Opportunities for Canada, University of Ottawa, November 23, 2007 audio by request

SemBioSys Biotechnologies, Calgary, Alberta, October 26, 2007

Synthetic Biology, Risks, Rewards, and Opportunities, Cross Cancer Institute, Edmonton, October 23 audio by request

Synthetic Viruses Targeting Cancer, SENS 3, Cambridge UK, September 7Video

Overview of synthetic biology, University of Lethbridge, July 19

University of Alberta Department Chairs and Divisional Directors Meeting, July 4

SB3.0 Poster -- iGEM: A case study for open source biological engineering

MIT TTT Canada overview May 26 Video

Digital Genetic Engineering, Google, May 3 Video

Alberta Ingenuity, January 17/18